Skip to Content

Ryzolt Approval History

  • FDA approved: Yes (First approved December 30th, 2008)
  • Brand name: Ryzolt
  • Generic name: tramadol
  • Dosage form: Extended Release Tablets
  • Company: Labopharm Inc.
  • Treatment for: Pain

Ryzolt (tramadol extended release) is a once-daily analgesic indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

Development History and FDA Approval Process for Ryzolt

Dec 31, 2008Approval Labopharm Announces FDA Approval of Once-Daily Ryzolt for Moderate to Moderately Severe Chronic Pain
Jul 17, 2008FDA Accepts Labopharm's Response for Once-Daily Tramadol as Complete Class 2 Response
Jul  3, 2008Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol
Jun 30, 2008Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
Apr  1, 2008Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
Jan 24, 2008Labopharm Receives FDA Response to Recent Appeal of Approvable Letter For Once-Daily Tramadol
Oct 15, 2007Labopharm Appeals FDA's Decision on Once-Daily Tramadol
Sep 25, 2007Labopharm Provides Update on U.S. Regulatory Process for Once-Daily Tramadol
Jun 29, 2007Labopharm Meets with FDA to Discuss Second Approvable Letter for Once-daily Tramadol
Jun  1, 2007Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.